Bladder Cancer Surgery

CONCLUSIONS: Having biological materials characterized and available along with the clinical patient information provides an integrated portrait of the patients and their diseases facilitating advances in molecular biology. It also promotes the development of translational research improving methods of diagnosis and cancer treatment. (Source: International Braz J Urol) Source: MedWorm: Bladder Cancer

You may have seen headlines about new data from a large, ongoing cancer study published this week in the journal Cancer which suggest that chemicals in processed red meat such as ham, bacon, hot dogs and bologna may be linked to bladder cancer. Experts at the American Institute for Cancer Research (AICR) have welcomed this new study, which adds to the considerable evidence linking diets high meat to greater cancer risk… (Source: Health News from Medical News Today)

Source: MedWorm: Bladder Cancer

Hormel Institute gets more than $1 million in research grants Post-Bulletin $316438 from the NIH to study the rare disease Fanconi anemia and the cancer development pathway, including bladder cancer. • $252405 from the US Department … Hormel Institute tours highlight research effortsPost-Bulletin all 2 news articles »

Source: bladder cancer – Google News

(University of Illinois College of Agricultural, Consumer and Environmental Sciences) Splashing around in a swimming pool on a hot summer day may not be as safe as you think. A recent University of Illinois study links the application of disinfectants in recreational pools to previously published adverse health outcomes such as asthma and bladder cancer. (Source: EurekAlert! – Medicine and Health) Source: MedWorm: Bladder Cancer

Researchers from Baylor College of Medicine’s Scott Department of Urology , Department of Molecular and Cellular Biology and the NCI-designated Dan L. Duncan Cancer Center are leading major efforts in bladder cancer research, both in the clinical and lab setting. Find out more about important advances in drug development, new theories about bladder cancer stem cells and the biology of the bladder from BCM researchers Dr. Guru Sonpavde, clinical assistant professor of medicine – hematology and oncology, Dr. Keith Syson Chan , assistant professor of urology and of molecular and cellular biology, Dr. Carolyn … (Source: Baylor College of Medicine News) Source: MedWorm: Bladder Cancer

Conclusions: TUcoreBxBT in cases of clear suspicion of invasive bladder cancer is a simple, short and safe procedure which makes it possible to collect reliable material for microscopic examination. TUcoreBxBT is less invasive than standard TURBT only in diagnosis and staging of invasive tumours, and seems to be effective in selected cases to confirm malignancy before radical cystectomy. (Source: Articles of Archives of Medical Science – TERMEDIA publishing house) Source: MedWorm: Bladder Cancer

Conclusions: Attention to sound design and statistical practice should be delivered as early as possible and will help maximize the promise of biomarkers for patient care. Studies should include a measure of predictive accuracy and clinical decision-analysis. External validation using data from an independent cohort provides the strongest evidence that a model is valid. There is a need for adequately assessed clinical biomarkers in bladder cancer. (Source: Urologic Oncology: Seminars and Original Investigations)

Source: MedWorm: Bladder Cancer

We present these findings in protest of the way in which they were acquired.For more information:
http://www.fasebj.org/cgi/content/abstract/fj.09-153841v2
http://nccam.nih.gov/health/probiotics/ (Source: NaturalNews.com) Source: MedWorm: Bladder Cancer

Conclusion: This qualitative research provides a better understanding on how men and women describe their LUTS and their perspectives on treatment outcomes. This research can be used to inform the development of a new LUTS outcomes’ tool. (Source: International Journal of Clinical Practice)

Source: MedWorm: Bladder Cancer

In collaboration with the National Cancer Centre, Singapore, Van Andel Research Institute (VARI) researchers have identified an enzyme that could help diagnose and treat cholangiocarcinoma, a form of liver cancer that strikes up to 3,000 new patients each year in the United States. Cholangiocarcinoma is the second most common type of cancer that affects the hepatobiliary system, which includes the liver, gall bladder, and bile ducts. The disease is most commonly diagnosed in patients in their 60’s and 70’s, and prognosis is generally poor with a 5-year survival rate of less than 5%… (Source: Health News from Medical News Today)

Source: MedWorm: Bladder Cancer